Microscopic Lung Collapses Spread Under Artificial Ventilation
A research team identifies microscopic clusters of damaged lung vesicles as the cause of massive loss of lung function.
Tag: ARDS acute respiratory distress syndrome
All
Latest
All
Latest
School Teacher Survives Two Double-Lung Transplants in Three Days
An elementary school teacher from Kentucky survived two double-lung transplants after a series of respiratory infections destroyed her lungs and hospitalized her for over a year.
All
Latest
Aerosolized mRNA Pneumonia Treatment Improved Symptoms in Preclinical Study
mRNA encoding immunomodulatory proteins IκBα-SR and SOD3 ameliorated symptoms in a bacterial pneumonia model.
Managing ARDS Risk in Pregnant Women
Coronavirus infections may be more frequent in pregnant women than in the general population, and those who contract the virus could also be more susceptible to acute respiratory distress syndrome.
Read More
A Healthy Microbiome Builds a Strong Immune System That Could Help Defeat COVID-19
Critically ill SARS-CoV-2 patients may have an altered gut microbiome that leads to acute respiratory distress syndrome.
Read More
Investigational Drug Gets DOD Funding to Prevent ARDS in COVID
Researchers evaluating whether an investigational oral drug, vadadustat, can help prevent acute respiratory distress syndrome in COVID-19 patients were awarded $5.1 million.
Read More
Immune System Malfunctions Distinguish COVID-19 Patients with ARDS
Patients with severe COVID-19 who develop ARDS have malfunctions in their immune systems that distinguish them from other COVID-19 patients.
Read More
FDA Authorizes CorVent Respond-19 Ventilator
The US FDA has issued an Emergency Use Authorization (EUA) for primary critical care use of CorVent Medical’s Respond-19 Ventilator.
Read More
High PEEP, Prone Positioning Beneficial for COVID-19-associated ARDS
High PEEP titration and prone positioning were as effective in treating early COVID-19 ARDS patients undergoing mechanical ventilation as classic ARDS.
Read More
NAVA Technology Reduces Length of Ventilation by Nearly 35%
According to the NAVIATOR trial, Getinge’s NAVA significantly increased the number of ventilator-free days and shortened the time of mechanical ventilation for adult patients with acute respiratory failure.
Read More
Fewer Fungi Types in Lungs Linked to Worse Disease in ARDS
New research has found that having fewer types of fungi in the lungs is linked to increased severity of disease in acute respiratory distress syndrome patients.
Read More
Dilated Lung Capillaries Likely Causing Hypoxemia in COVID-19 Patients
The novel coronavirus is causing significant dilation of lung capillaries and this vasodilation is contributing to the very low oxygen levels seen in COVID-19 respiratory failure.
Read More
Reducing Severe Dyspnea, PTSD in COVID-19 ARDS Survivors
Research has shown that, among ICU survivors of COVID-19-related ARDS, the experience of “air hunger” (or severe dyspnea) is often associated with post-traumatic stress disorder.
Read More
Study: Glucocorticoids Are Harmful in Treating Viral Respiratory Infections
Glucocorticoids are widely used in treating acute respiratory distress syndrome (ARDS), but a new study shows that this treatment could lead to higher death rates.
Read More
Analysis Could Not Find Two Distinct Subphenotypes of COVID-19-related ARDS
Researchers have been unable to produce two theorized subphenotypes of COVID-19 related ARDS, the more typical ‘H type’ and a variant ‘L type.’
Read More